Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart L Fine
Daniel F Martin
Peter Kirkpatrick

Showing results (241-250 of 252) with videos related to

Pageof 26
Sort By:
Ophthalmology. Retina|November 20, 2025
Risk Factors and Systemic Outcomes in Patients with Retinal Artery OcclusionAusten N Knapp, Matthew J Schulgit, Sumit Sharma, et al.
JAMA Ophthalmology|July 26, 2018
Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical TrialJeffrey G Gross, Adam R Glassman, Danni Liu, et al.
Ophthalmology Science|May 1, 2026
Oral Tonabersat Connexin-43 Modulator for Diabetic Macular Edema with Good Vision (DRCR Retina Network Protocol AN)Andrew J Barkmeier, Thu P Vu, Michael Elman, et al.
The Cochrane Database of Systematic Reviews|September 16, 2014
Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degenerationLorenzo Moja, Ersilia Lucenteforte, Koren H Kwag, et al.
Ophthalmology. Retina|January 30, 2026
Outcomes and Complications of Pars Plana Vitrectomy for Non-clearing Vitreous Hemorrhage without Tractional ElementsJustin C Muste, Matthew J Schulgit, Scott Perkins, et al.
The New England Journal of Medicine|July 14, 2022
Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular EdemaChirag D Jhaveri, Adam R Glassman, Frederick L Ferris, et al.
JAMA Ophthalmology|October 30, 2015
Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema: Extrapolation of Data to Clinical PracticeJeffrey S Heier, Neil M Bressler, Robert L Avery, et al.
Ophthalmology|September 6, 2016
Long-term Management of Panuveitis and Iris Heterochromia in an Ebola SurvivorJessica G Shantha, Ian Crozier, Jay B Varkey, et al.
Ophthalmology. Retina|October 15, 2020
Patient-Reported Complications after Intravitreal Injection and Their Predictive FactorsMichael S Ramos, Lucy T Xu, Srinidhi Singuri, et al.
Journal of Neurosurgery|July 2, 2021
Rescue therapy for vasospasm following aneurysmal subarachnoid hemorrhage: a propensity score-matched analysis with machine learningMichael L Martini, Sean N Neifert, William H Shuman, et al.
Pageof 26

Showing results (241-250 of 252) with videos related to

Sort By:
Pageof 26
Ophthalmology. Retina|November 20, 2025
Risk Factors and Systemic Outcomes in Patients with Retinal Artery OcclusionAusten N Knapp, Matthew J Schulgit, Sumit Sharma, et al.
JAMA Ophthalmology|July 26, 2018
Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical TrialJeffrey G Gross, Adam R Glassman, Danni Liu, et al.
Ophthalmology Science|May 1, 2026
Oral Tonabersat Connexin-43 Modulator for Diabetic Macular Edema with Good Vision (DRCR Retina Network Protocol AN)Andrew J Barkmeier, Thu P Vu, Michael Elman, et al.
The Cochrane Database of Systematic Reviews|September 16, 2014
Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degenerationLorenzo Moja, Ersilia Lucenteforte, Koren H Kwag, et al.
Ophthalmology. Retina|January 30, 2026
Outcomes and Complications of Pars Plana Vitrectomy for Non-clearing Vitreous Hemorrhage without Tractional ElementsJustin C Muste, Matthew J Schulgit, Scott Perkins, et al.
The New England Journal of Medicine|July 14, 2022
Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular EdemaChirag D Jhaveri, Adam R Glassman, Frederick L Ferris, et al.
JAMA Ophthalmology|October 30, 2015
Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema: Extrapolation of Data to Clinical PracticeJeffrey S Heier, Neil M Bressler, Robert L Avery, et al.
Ophthalmology|September 6, 2016
Long-term Management of Panuveitis and Iris Heterochromia in an Ebola SurvivorJessica G Shantha, Ian Crozier, Jay B Varkey, et al.
Ophthalmology. Retina|October 15, 2020
Patient-Reported Complications after Intravitreal Injection and Their Predictive FactorsMichael S Ramos, Lucy T Xu, Srinidhi Singuri, et al.
Journal of Neurosurgery|July 2, 2021
Rescue therapy for vasospasm following aneurysmal subarachnoid hemorrhage: a propensity score-matched analysis with machine learningMichael L Martini, Sean N Neifert, William H Shuman, et al.
Pageof 26